Mebhydrolin or mebhydroline
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313406This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H20N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9SUK9B7XVY, chemically known as 5-benzyl-1,3,4,5-tetrahydro-2-methyl-2h-pyrido(4,3-b)indole but generally known as mebhydrolin, which bears US NIH Compound Identifier 22530. European Medicines Agency schedules Mebhydrolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08664MIG. The term MEBHYDROLIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules mebhydrolin in its Anatomical Therapeutic Chemical (ATC) Classification. MEBHYDROLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Mebhydrolin or mebhydroline bears US NLM identifiers UMLS ID C0065834 and NCI Concept Code C66059. SMILES: CN1CCC2=C(C1)C3=CC=CC=C3N2CC4=CC=CC=C4.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.